Our Angio-H Tablets are a more recent blood pressure medication referred to as an angiotensin II receptor blocker (ARB for short). Telmisartan inhibits the angiotensin II receptors, as the name indicates. It reduces the efficacy of angiotensin II, a hormone that usually causes blood vessels to contract (constrict). Telmisartan induces blood arteries to relax by inhibiting the actions of angiotensin II.
Additionally, this Angio-H Tablets collection contains a diuretic, sometimes known as a "water pill." It does this by boosting the quantity of sodium and water removed from the blood by the kidneys. This excess sodium and water is excreted in the urine. Thus, our Angio-H Tablets range promotes a drop in blood volume by increasing the quantity of water eliminated from the circulation.Uses and Indications:
- Hypertension - (Hypertension)
- Interactions with Other Drugs
- Complementary mechanisms of action
- ARB induces a decrease in peripheral resistance
- Diuretics are used to decrease fluid volume.
- ARBs mitigate the hypertensive response to diuretic-induced rennin secretion.
- ARBs counteract the potassium depletion caused by diuretics.
- Tolerable; minimal metabolic abnormalities
Telmisartan's pharmacokinetic characteristics did not change significantly in the presence of hydrochlorothiazide.
Angio-H Tablets in combination with hydrochlorothiazide were shown to be more effective in lowering blood pressure than either drug alone. Indeed, combining telmisartan with hydrochlorothiazide improves telmisartan's antihypertensive effectiveness in individuals who are not sufficiently managed with telmisartan alone. Pharmacokinetics: Our Angio-H Tablets are absorbed orally and converted to a more powerful AT1 antagonist than Losartan. Hydrochlorothiazide is rapidly absorbed and begins exerting its diuretic action within an hour, lasting up to 12-24 hours. Angio-H Tablets and hydrochlorothiazide both have a longer half-life. These agents exhibit different degrees of affinity for plasma proteins, which has no bearing on their half-life.
Telmisartan & hydrochlorothiazide's pharmacodynamics have been studied in vitro and in vivo in rats, guinea pigs, rabbits, and dogs. Telmisartan with hydrochlorothiazide (40 mg/12.5 mg or 80 mg/12.5 mg) is intended to assist individuals with hypertension who do not respond satisfactorily to telmisartan alone.Contraindications:
- Pregnancy is divided into two trimesters.
- Disorders of the biliary duct.
- Hepatic insufficiency is severe.
It is a novel combination of anti-inflammatory and analgesic agents that acts as a muscle relaxant. The gastrointestinal system readily absorbs Thiocolchicoside and Diclofenac Sodium. Our Angio-H Tablets begin to work within one to two hours of oral ingestion. This combination is used to alleviate the pain associated with a variety of inflammatory diseases.
Diclofenac Sodium exhibits an exceptional anti-inflammatory profile, principally by reducing cyclooxygenase (COX) activity and inhibiting PGE2 production. As a result of the discussion above, it can be concluded that this medication can improve patients' quality of life while also acting as a muscle relaxant. Additionally, it has a high safety profile with long-lasting effects.
No specific temperature storage requirements are required for this medical medication. Instead, protect from moisture by storing in the original packaging.